NPI registry status
Active
2026 NPPES data Hematology & Oncology Physician NPI 1306094842 M.D.
Verify on CMS → Nina Yedavalli, M.D.
Hematology & Oncology Physician in Joliet, Illinois.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,232 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
626
Medicare Part D claims · 166 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
84%
generic claims · 16% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$99
1 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Nina Yedavalli, M.D. filed 626 Medicare Part D claims in 2023 as a Hematology & Oncology Physician in Joliet, Illinois, prescribing 84% generic.
- 626
- Part D claims, 2023
- 84%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Nina Yedavalli, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
626 Top 31% higher than 69% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
✓
Board certification likely (heuristic, not verified)
Nina Yedavalli, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 2 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Nina Yedavalli, M.D.?
Quality data not reportedPrimary specialty
Hematology & Oncology Physician
Medicare Part D claims
626 26% vs specialty avg
Specialty distribution in Illinois
How Hematology & Oncology Physician compares to other specialties among Illinois providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Hematology & Oncology Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Nina Yedavalli, M.D. appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding M.D. credentials at 1301 COPPERFIELD AVE, Joliet, IL, 60432, with a listed phone of (815) 740-1400. NPI 1306094842 was issued on 09/08/2008.
Medicare Part D records for calendar year 2023 show 626 prescription claims written by this provider, covering 166 Medicare beneficiaries and totaling roughly $1.5 million in drug spend, split 16% brand-name and 84% generic by claim count, with an opioid prescribing rate of 4.6%.
Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,232 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1306094842 |
|---|---|
| Specialty | Hematology & Oncology Physician |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 09/08/2008 |
Hospital and facility affiliations
Facilities where Nina Yedavalli, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Loyola University Medical Center
★★☆☆☆ 2/5
Maywood, IL
Acute Care Hospitals
CMS CCN: 140276
Loyola Medical Group LLC
Berwyn, IL
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Nina Yedavalli, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$99
Largest payer
Gilead Sciences, Inc.
Most common payment type
Education
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Illinois IDFPR 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~42K Illinois medical licensees in 2023 - they are NOT specific to Nina Yedavalli, M.D.. To verify Nina Yedavalli, M.D.'s current license status, search the IDFPR public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
106
Total board actions, Illinois 2023
Across 103 cases
2.52
Actions per 1,000 licensees
Illinois statewide rate
probation
Most common action type
38 cases
IDFPR publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Illinois disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
Nina Yedavalli, M.D. - brand share 16.0%
Hematology & Oncology Physician average
16% brand-name claims vs 84% generic, on 626 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
626
Total Claims
$1.5M
Total Drug Cost
166
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,129
- Total Day Supply
- 30,092
- Brand vs Generic
- 16% brand / 84% generic
- Brand Drug Cost
- $1.4M
- Generic Drug Cost
- $75K
- Opioid Claims
- 29 (4.6% rate)
Patient Demographics
- Average Patient Age
- 74.3 years
- Avg HCC Risk Score
- 1.90
- Gender Split
- 74% female / 26% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Nina Yedavalli, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Anastrozole
Anastrozole
190 claims
- Dexamethasone 73
Dexamethasone
73 claims
- Letrozole 44
Letrozole
44 claims
- Prochlorperazine M… 35
Prochlorperazine Maleate
35 claims
- Hydroxyurea 30
Hydroxyurea
30 claims
- Abiraterone Acetate 24
Abiraterone Acetate
24 claims
- Hydrocodone-Acetam… 24
Hydrocodone-Acetaminophen
24 claims
- Tagrisso 19
Tagrisso
19 claims
| Drug | Claims |
|---|---|
| Anastrozole | 190 |
| Dexamethasone | 73 |
| Letrozole | 44 |
| Prochlorperazine Maleate | 35 |
| Hydroxyurea | 30 |
| Abiraterone Acetate | 24 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 24 |
| Tagrisso Osimertinib Mesylate | 19 |
| Prednisone | 16 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 13 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Hematology & Oncology Physician Overview
How Nina Yedavalli, M.D. fits within the Hematology & Oncology Physician landscape nationally.
11,232
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider
Nina Yedavalli, M.D.'s 626 claims are below the specialty average of 847.
Nearby Hematology & Oncology Physician Providers in Illinois
Other clinicians with the same primary specialty enrolled in Illinois, drawn from the same CMS NPPES roster as Yedavalli.
Dr. Yasmin Abaza
M.D.
Chicago, IL
Dr. Worood Abboud
M.D.
Joliet, IL
Dr. Sabree Abedrabo
MD
Park Ridge, IL
Dr. Majed Abuhajir
MD
Rockford, IL
Dr. Kehinde Adekola
MD
Chicago, IL
Compare Hematology & Oncology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Illinois medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Hematology & Oncology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Illinois
Frequently Asked Questions
What is Nina Yedavalli, M.D.'s specialty? ▼
Nina Yedavalli, M.D. specializes in Hematology & Oncology Physician and practices in Joliet, Illinois. Credentials: M.D..
How much does Nina Yedavalli, M.D. prescribe under Medicare Part D? ▼
In 2023, Nina Yedavalli, M.D. wrote 626 Medicare Part D claims totaling $1.5M in drug costs for 166 beneficiaries.
Where is Nina Yedavalli, M.D. located? ▼
Nina Yedavalli, M.D. is located at 1301 COPPERFIELD AVE, Joliet, IL, 60432. Phone: (815) 740-1400.
What is Nina Yedavalli, M.D.'s NPI number? ▼
Nina Yedavalli, M.D.'s National Provider Identifier (NPI) is 1306094842, issued on 09/08/2008.
Does Nina Yedavalli, M.D. prescribe more brand-name or generic drugs? ▼
Nina Yedavalli, M.D.'s prescribing is 16% brand-name and 84% generic drugs by claim count, with $1.4M in brand drug costs.
Does Nina Yedavalli, M.D. prescribe opioids? ▼
Yes, Nina Yedavalli, M.D. had 29 opioid claims in 2023 with an opioid prescribing rate of 4.6%.
How many Hematology & Oncology Physician providers are there in the US? ▼
There are 11,232 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does Nina Yedavalli, M.D. prescribe most often? ▼
Based on 2023 Medicare Part D data, Nina Yedavalli, M.D.'s most frequently prescribed drugs include Anastrozole, Dexamethasone, Letrozole. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Nina Yedavalli, M.D. accept Medicare? ▼
Nina Yedavalli, M.D. appears in CMS Medicare data with 626 Part D claims and 166 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Nina Yedavalli, M.D.'s credentials? ▼
Nina Yedavalli, M.D.'s NPI is 1306094842 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.